Evidence map›Paper›PMID 28117754›Full record

ReviewInternational journal of molecular sciences2017

What Do We Know about Opioids and the Kidney?

Mary Mallappallil, Jacob Sabu, Eli A Friedman, Moro Salifu

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
10.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mary MallappallilDepartment of Internal Medicine, State University of New York at Downstate, Brooklyn, New York, NY 11203, USA. marynephrology@yahoo.com.
Jacob SabuDepartment of Internal Medicine, State University of New York at Downstate, Brooklyn, New York, NY 11203, USA. sabujacob111@gmail.com.
Eli A FriedmanDepartment of Internal Medicine, State University of New York at Downstate, Brooklyn, New York, NY 11203, USA. elifriedmn@aol.com.
Moro SalifuDepartment of Internal Medicine, State University of New York at Downstate, Brooklyn, New York, NY 11203, USA. moro.salifu@downstate.edu.
State University of New York · USSUNY Downstate Health Sciences University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence suggests a link between opioid use and kidney disease. This review summarizes the known renal manifestations of opioid use including its role in acute and chronic kidney injury. Both the direct and indirect effects of the drug, and the context which leads to the development of renal failure, are explored. While commonly used safely for pain control and anesthesia in those with kidney disease, the concerns with respect to side effects and toxicity of opioids are addressed. This is especially relevant with the worldwide increase in the use of opioids for medical and recreational use.

Indexed as

Acute Kidney InjuryAnalgesics, OpioidHumansIncidenceKidneyRenal InsufficiencyAnalgesics, Opioidopioidspharmacokineticsrenal failure

Identifiers

PMID28117754
PMCPMC5297852
OpenAlexW2581749317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.